Aseel Alsouqi
Aseel Alsouqi
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome | Recurrent Transformed B-Cell Non-Hodgkin Lymphoma; Recurrent Transformed Chronic Lymphocytic Leukemia; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory Transformed; Refractory Transformed B-cell Non-Hodgkin Lymphoma; Refractory Transformed Chronic Lymphocytic Leukemia; Refractory Transformed Non-Hodgkin Lymphoma; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Recruiting | Phase 2 | 2026-03-03 | NCT05873712 |